Structured Non-operative Treatment of Knee Osteoarthritis

Status Completed

Clinical Trial Summary

The purpose of this study is to test whether an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, non steroidal anti inflammatory drugs (NSAIDs) and Pantoprazole provides further improvement in pain, function and quality of life than standard non-surgical treatment (information on the disease and how to treat it) in patients with knee osteoarthritis.

The H1-hypothesis is that the treatment algorithm results in a greater increase in quality of life and functional capacity and greater reduction in pain than standard treatment at the primary endpoint, which is follow-up 12months after the start of the treatment.

See statistical analysis plan available under "Links" for further description of the study.

Clinical Trial Description

Knee osteoarthritis (OA) is the degenerative joint disease that most often requires treatment and at the same time the one associated with the greatest social costs. In addition, the disease has many personal costs and is greatly contributing to reduced functionality and autonomy of older adults.

It is recommended both nationally and internationally that the treatment of knee osteoarthritis should include multiple treatment modalities. Clinical guidelines recommend that exercise, weight loss and patient education is the first step in treatment and that insoles and pharmacological treatment can be included as a supplement.

However if the patient is not a candidate for total knee replacement, the patient most often receives only information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse. This postponement of treatment can lead to a worsening of pain and function and a worse outcome after treatment. Therefore, the current treatment strategy for the patient group is problematic.

The current practice may be due to the lack of studies with high level of evidence that have examined the optimal non-operative treatment approach and compared it with the current standard treatment for this group of patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01535001
Study type	Interventional
Source	Northern Orthopaedic Division, Denmark
Contact
Status	Completed
Phase	N/A
Start date	February 2012
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03277066` - A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis	Phase 2
Recruiting	`NCT03090698` - Outcomes of Injections in Patients Waiting for Total Knee Replacement	Phase 4
Completed	`NCT02556710` - A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee	Phase 3
Withdrawn	`NCT02237846` - Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis	Phase 1/Phase 2
Completed	`NCT02242435` - A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis	Phase 3
Completed	`NCT02096393` - Patient Specific Instrumentation in TKR	N/A
Completed	`NCT01849445` - Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study	N/A
Completed	`NCT01704157` - A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device	N/A
Active, not recruiting	`NCT01374230` - Long-Term Multicenter Evaluation of the E1® Tibial Bearing	N/A
Completed	`NCT01410409` - Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement	N/A
Completed	`NCT02156440` - Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee	Phase 2
Not yet recruiting	`NCT01270412` - Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis	Phase 2/Phase 3
Completed	`NCT01207115` - A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee	Phase 2
Completed	`NCT01331278` - A Comparative Study of Knee Systems	Phase 4
Completed	`NCT00970008` - Exploring Massage Benefits for Arthritis of the Knee	Phase 2
Completed	`NCT00988091` - Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee	Phase 3
Completed	`NCT00531427` - Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee	Phase 3
Completed	`NCT00792727` - HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain	Phase 3
Completed	`NCT00449696` - Gel-200 Versus Placebo in Osteoarthritis of the Knee	Phase 3
Completed	`NCT04145011` - Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.